All In Biotech

Free tool

FAERS Monitor: Avastin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125085 or its brand name (Avastin, Bevacizumab). Reports on generic versions are filed under their own applications.

Reports

125,237

Serious

114,342

91% of reports

Hospitalization

40,518

Death reported

28,436

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use14,881
  • death13,302
  • diarrhoea7,457
  • disease progression7,448
  • fatigue6,622
  • nausea6,613
  • hypertension5,933
  • vomiting5,030
  • anaemia4,505
  • pyrexia4,134
  • neutropenia4,092
  • asthenia3,624
  • decreased appetite3,521
  • dyspnoea3,465
  • thrombocytopenia3,452

Reports by year received

View as table
YearReports
2004638
20051,129
20061,709
20072,188
20083,135
20093,354
20103,388
20113,446
20129,608
20135,546
20144,774
20154,948
20165,149
20177,561
20187,178
20196,405
20206,492
20217,914
20228,089
20238,847
20248,482
20258,818
20266,439

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,928,922 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
disease progressionSignal7,44811.211.065,288
thrombocytopeniaSignal3,4525.35.111,787
neutropeniaSignal4,0925.25.013,471
hypertensionSignal5,9334.84.717,585
anaemiaSignal4,5054.03.910,146
off label useSignal14,8812.92.818,813
deathSignal13,3022.62.613,655
decreased appetiteSignal3,5212.62.53,361
pyrexiaSignal4,1342.02.02,134
diarrhoea7,4572.01.93,525
vomiting5,0301.81.81,828
asthenia3,6241.61.6877
fatigue6,6221.41.4889
nausea6,6131.41.4801
dyspnoea3,4651.01.03

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.